Evidence map›Paper›PMID 39088848›Full record

ArticleACS applied materials & interfaces2024

A Supramolecular Antibiotic Targeting Drug-Resistant

Cheng Jiang, Lei Zheng, Yu-Jie Yan, Miao Wang, Xiao-Jing Liu, Jing-Yao Dai

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. A novel approach to combatMicrobiology spectrum · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cheng JiangDepartment of Hepatobiliary Surgery, Air Force Medical Center, Fourth Military Medical University, Beijing 100142, PR China.ORCID 0009-0006-7834-2512
Lei ZhengDepartment of Hepatobiliary Surgery, Air Force Medical Center, Fourth Military Medical University, Beijing 100142, PR China.
Yu-Jie YanThe College of Life Sciences, Northwest University, Xi'an, Shaanxi 710072, China.
Miao WangKey Laboratory for Space Biosciences and Biotechnology, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China.
Xiao-Jing LiuDepartment of Infectious Disease, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, PR China.
Jing-Yao DaiDepartment of Hepatobiliary Surgery, Air Force Medical Center, Fourth Military Medical University, Beijing 100142, PR China.ORCID 0000-0001-8510-3647

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The bacterium

Indexed as

Anti-Bacterial AgentsPseudomonas aeruginosaPseudomonas InfectionsVirulence FactorsAdaptive ImmunityAnimalsDrug Resistance, BacterialFemaleHumansMiceMice, Inbred BALB CMicrobial Sensitivity TestsAnti-Bacterial AgentsVirulence FactorsantibioticsdHTSN1nanoparticlesPseudomonas aeruginosa resistanceT3SS

Identifiers

PMID39088848
PMCPMC11331443

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.